Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

Insulin Formulations: Types and Delivery

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...

Insulin: Biosynthesis, Chemistry, and Preparation

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Production of Pharmaceuticals

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...

Dosage Regimen: Individualization

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Patient Satisfaction and Clinical Experience With the Tandem t:slim X2 With Control-IQ Technology Advanced Hybrid Closed-Loop Insulin Delivery System.

Diabetes spectrum : a publication of the American Diabetes Association·2024

Same author

Significant publications in diabetes pharmacotherapy and technology in 2020.

Expert review of endocrinology & metabolism·2023

Same author

Evaluation of Clinical Outcomes With the V-Go Wearable Insulin Delivery Device in Patients With Type 2 Diabetes.

Clinical diabetes : a publication of the American Diabetes Association·2021

Same author

The Effect of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors in Patients Prescribed Regular U-500 Insulin.

The Annals of pharmacotherapy·2019

Same author

Evaluation of Diabetes Education and Pharmacist Interventions in a Rural, Primary Care Setting.

Diabetes spectrum : a publication of the American Diabetes Association·2018

Same author

Clinical Experience with U-500 Regular Insulin by Multiple Daily Injections and Continuous Subcutaneous Insulin Infusion.

Diabetes technology & therapeutics·2017

Same journal

Correction to 'Competencies for Diabetes Care and Education Specialists' by Ryan et al. <i>The Diabetes Educator</i> 46(4), pages 384-397 (August 2020).

The Diabetes educator·2020

Same journal

<i>The Diabetes Educator</i> (<i>TDE</i>): Successes, Opportunities, and Future Changes.

The Diabetes educator·2020

Same journal

An Umbrella Review of Text Message Programs for Adults With Type 2 Diabetes.

The Diabetes educator·2020

Same journal

Community-Based Participatory Research Interventions to Improve Diabetes Outcomes: A Systematic Review.

The Diabetes educator·2020

Same journal

"Together We Can Return to Balance"-Eastern Woodlands Native Perspectives and Type 2 Diabetes: A Qualitative Study.

The Diabetes educator·2020

Same journal

The Healthy Eating and Living Against Noncommunicable Diseases Study: An Innovative Family-Based Intervention.

The Diabetes educator·2020

See all related articles

Search research articles

Related Experiment Video

Updated: May 7, 2026

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Optimizing insulin pump therapy: a quality improvement project.

Lisa T Meade^1,2, Wanda E Rushton¹

¹Department of Endocrinology, Piedmont HealthCare, Statesville, NC, USA (Dr Meade, Ms Rushton)

The Diabetes Educator

|September 19, 2013

Summary

This summary is machine-generated.

This study assessed insulin pump use via a questionnaire, identifying common patient deficiencies. Targeted education can improve self-management and prevent adverse events in diabetes care.

More Related Videos

Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults

Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults

Published on: December 1, 2023

Related Experiment Videos

Last Updated: May 7, 2026

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults

Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults

Published on: December 1, 2023

Area of Science:

Endocrinology
Diabetes Management
Medical Devices

Background:

Insulin pump therapy is crucial for diabetes management.
Ongoing assessment and education are vital for optimizing insulin pump use.
Patient understanding of device operations and troubleshooting is essential.

Purpose of the Study:

To evaluate current insulin pump usage patterns.
To identify deficiencies in patient self-management of insulin pumps.
To inform targeted educational interventions for insulin pump users.

Main Methods:

A quality improvement project utilized a pump assessment questionnaire.
Eighty-nine patients with type 1 and type 2 diabetes participated.
A certified diabetes educator reviewed questionnaire responses with patients.

Main Results:

Common deficiencies included issues with basal insulin prescriptions, site infection management, and sick day protocols.
Patients demonstrated suboptimal use of advanced features like bolus calculators.
Lack of readily available supplies (syringes, glucagon kits) was also noted.

Conclusions:

Pump assessment questionnaires facilitate focused discussions on patient behaviors.
Routine use of these questionnaires can enhance patient education.
This approach may help prevent adverse events associated with insulin pump therapy.